The dopamine transporter (DAT) is the plasmalemmal membrane protein that mediates the inactivation of released dopamine through its reuptake. DAT is the major molecular target responsible for the rewarding properties and abuse potential of cocaine, amphetamine, and related psychostimulants. Homologous neurotransmitter transporters for serotonin and norepinephrine are targets for antidepressant medications as well as secondary targets for psychostimulants. The long-term goals of this research are to determine the structural bases of substrate translocation and of efflux induced by psychostimulant substrates such as amphetamine. More specifically, we would like to understand whether DAT-mediated amphetamine-induced dopamine efflux can be blocked while simultaneously preserving dopamine transport and how this would alter the behavioral and neurotoxic effects of amphetamine. For the next grant period, we propose to test the following hypotheses: a) Phosphorylation of specific serines in the N-terminus of DAT switches the transporter from a """"""""resistant"""""""" to a """"""""willing"""""""" state for amphetamine-induced efflux, b) Phosphorylation of the N-terminus regulates its interaction with the N-terminus of another DAT at an oligomeric interface, c) Distinct kinases are responsible for regulated phosphorylation of the N-terminal serines, d) Amphetamine-induced dopamine-efflux, and not simply blockade of uptake, is responsible for some of the behavioral effects of acute and/or chronic amphetamine in vivo. To test these hypotheses, we propose studies with the following specific aims: 1) To identify the sites of DAT N-terminal phosphorylation and the functional role of phosphorylation. 2) To identify elements in the N-terminus and their interactions at an oligomeric interface with the N-terminus of another DAT and to assess the impact of phosphorylation on these interactions. 3) To identify the kinase or kinases involved in phosphorylating these N-terminal serines. There are numerous advantages to pursuing these studies as part of the proposed Program Project grant. Much of the work carried out during this grant period was conducted as part of collaborations with Aurelio Galli, Ulrik Gether, or Harel Weinstein, and substantial synergies have been achieved through our interactions. Continued building upon these synergies is reflected in the proposed aims of this project, as well as in the interplay of our related aims and, in some cases, related methodologies.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA012408-09
Application #
7406011
Study Section
Special Emphasis Panel (ZDA1)
Project Start
Project End
Budget Start
2008-01-01
Budget End
2008-12-31
Support Year
9
Fiscal Year
2007
Total Cost
$210,656
Indirect Cost
Name
Weill Medical College of Cornell University
Department
Type
DUNS #
060217502
City
New York
State
NY
Country
United States
Zip Code
10065
Mayer, Felix P; Schmid, Diethart; Owens, W Anthony et al. (2018) An unsuspected role for organic cation transporter 3 in the actions of amphetamine. Neuropsychopharmacology 43:2408-2417
Quick, Matthias; Abramyan, Ara M; Wiriyasermkul, Pattama et al. (2018) The LeuT-fold neurotransmitter:sodium symporter MhsT has two substrate sites. Proc Natl Acad Sci U S A 115:E7924-E7931
Herborg, Freja; Andreassen, Thorvald F; Berlin, Frida et al. (2018) Neuropsychiatric disease-associated genetic variants of the dopamine transporter display heterogeneous molecular phenotypes. J Biol Chem 293:7250-7262
Razavi, Asghar M; Khelashvili, George; Weinstein, Harel (2018) How structural elements evolving from bacterial to human SLC6 transporters enabled new functional properties. BMC Biol 16:31
Doktorova, Milka; Weinstein, Harel (2018) Accurate In Silico Modeling of Asymmetric Bilayers Based on Biophysical Principles. Biophys J 115:1638-1643
LeVine, Michael V; Cuendet, Michel A; Razavi, Asghar M et al. (2018) Thermodynamic Coupling Function Analysis of Allosteric Mechanisms in the Human Dopamine Transporter. Biophys J 114:10-14
Stolzenberg, Sebastian; Li, Zheng; Quick, Matthias et al. (2017) The role of transmembrane segment 5 (TM5) in Na2 release and the conformational transition of neurotransmitter:sodium symporters toward the inward-open state. J Biol Chem 292:7372-7384
Razavi, Asghar M; Khelashvili, George; Weinstein, Harel (2017) A Markov State-based Quantitative Kinetic Model of Sodium Release from the Dopamine Transporter. Sci Rep 7:40076
Sahai, Michelle A; Davidson, Colin; Khelashvili, George et al. (2017) Combined in vitro and in silico approaches to the assessment of stimulant properties of novel psychoactive substances - The case of the benzofuran 5-MAPB. Prog Neuropsychopharmacol Biol Psychiatry 75:1-9
Gregorio, G Glenn; Masureel, Matthieu; Hilger, Daniel et al. (2017) Single-molecule analysis of ligand efficacy in ?2AR-G-protein activation. Nature 547:68-73

Showing the most recent 10 out of 146 publications